Get Connected:

The MD Magazine condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Anakinra Aids Severe Hidradenitis Suppurativa
Interleukin 1 receptor antagonist Anakinra was found to benefit patients afflicted with severe hidradenitis suppurativa, a common skin disorder characterized by excessive inflammation.
The severity of nail and scalp psoriasis was significantly reduced in patients who received twice-daily treatment with Otezla (apremilast, Celgene).
Younger patients may get a bad rep for misusing prescription medications, but they do not make up the prominent group who get the interventions.
Empathy can be an effective tool for reducing pain, according to results from a placebo analgesia study published in the Proceedings of the National Academy of Science.
Supposedly “unbeatable” eczema (atopic dermatitis) can be successfully treated using tofacitinib, suggest findings published in the Journal of the American Academy of Dermatology.
Researchers have revealed the discovery of a new gene that allows bacteria to become resistant to colistin, considered the “last line of defense” to antibiotic resistance.
Researchers sought to identify characteristics associated with past malpractice lawsuits and how malpractice concerns may affect interpretive practices among dermatopathologists.

Most Popular

$vacMongoViewPlus$ $vAR$